BACKGROUND AND OBJECTIVE: There is general agreement that certain fatty acids and lipopolysaccharides (LPS) promote inflammation through toll-like receptor 4 (TLR4), and that inflammation promotes insulin resistance. We therefore hypothesized that mice with periodontitis and a TLR4 loss-of-function (LOF) mutation fed a high-fat (HF) diet would develop improved glucose homeostasis compared with wild-type (WT) animals with periodontitis fed a HF diet. MATERIAL AND METHODS: Wild-type and TLR4 mutant mice fed a HF diet were divided into four groups (n = 6/group): WT; WT with periodontitis (WT/P); mutant (Mut); and mutant with periodontitis (Mut/P). Periodontitis was induced by placing LPS soaked ligatures around maxillary second molars. Fasting insulin and glucose levels were measured weekly for 10 wk. Glucose tolerance was evaluated at baseline (week 1) and at 9 wk. Insulin signaling (phosphorylation of Akt) and tumor necrosis factor-α (TNF-α) mRNA levels in liver were determined when the mice were killed at week 10. RESULTS: Mut/P mice developed less alveolar bone loss compared with WT/P mice (p < 0.05). Fasting glucose levels were improved after 8 wk of feeding a HF diet (weeks 9 and 10) in Mut/P mice compared with Mut, WT and WT/P mice (p < 0.05). Glucose tolerance was impaired in all groups compared with baseline (p < 0.05), except for the Mut/P group. Insulin signaling was improved (p < 0.05), and expression of TNF-α was decreased (p < 0.05) in the liver of Mut/P mice compared with the liver of WT/P mice. CONCLUSION: The TLR4 LOF mutation partially protects against alveolar bone loss and improves glucose homeostasis in mice with periodontitis fed a HF diet.
BACKGROUND AND OBJECTIVE: There is general agreement that certain fatty acids and lipopolysaccharides (LPS) promote inflammation through toll-like receptor 4 (TLR4), and that inflammation promotes insulin resistance. We therefore hypothesized that mice with periodontitis and a TLR4 loss-of-function (LOF) mutation fed a high-fat (HF) diet would develop improved glucose homeostasis compared with wild-type (WT) animals with periodontitis fed a HF diet. MATERIAL AND METHODS: Wild-type and TLR4 mutant mice fed a HF diet were divided into four groups (n = 6/group): WT; WT with periodontitis (WT/P); mutant (Mut); and mutant with periodontitis (Mut/P). Periodontitis was induced by placing LPS soaked ligatures around maxillary second molars. Fasting insulin and glucose levels were measured weekly for 10 wk. Glucose tolerance was evaluated at baseline (week 1) and at 9 wk. Insulin signaling (phosphorylation of Akt) and tumor necrosis factor-α (TNF-α) mRNA levels in liver were determined when the mice were killed at week 10. RESULTS: Mut/P mice developed less alveolar bone loss compared with WT/P mice (p < 0.05). Fasting glucose levels were improved after 8 wk of feeding a HF diet (weeks 9 and 10) in Mut/P mice compared with Mut, WT and WT/P mice (p < 0.05). Glucose tolerance was impaired in all groups compared with baseline (p < 0.05), except for the Mut/P group. Insulin signaling was improved (p < 0.05), and expression of TNF-α was decreased (p < 0.05) in the liver of Mut/P mice compared with the liver of WT/P mice. CONCLUSION: The TLR4 LOF mutation partially protects against alveolar bone loss and improves glucose homeostasis in mice with periodontitis fed a HF diet.
Authors: M Vives-Pi; N Somoza; J Fernández-Alvarez; F Vargas; P Caro; A Alba; R Gomis; M O Labeta; R Pujol-Borrell Journal: Clin Exp Immunol Date: 2003-08 Impact factor: 4.330
Authors: D F Kinane; H Shiba; P G Stathopoulou; H Zhao; D F Lappin; A Singh; M A Eskan; S Beckers; S Waigel; B Alpert; T B Knudsen Journal: Genes Immun Date: 2006-04 Impact factor: 2.676
Authors: Amy R Weatherill; Joo Y Lee; Ling Zhao; Danielle G Lemay; Hyung S Youn; Daniel H Hwang Journal: J Immunol Date: 2005-05-01 Impact factor: 5.422
Authors: Alex Rafacho; Tânia M Cestari; Sebastião R Taboga; Antonio C Boschero; José R Bosqueiro Journal: Am J Physiol Endocrinol Metab Date: 2009-01-21 Impact factor: 4.310
Authors: Sara M Reyna; Sangeeta Ghosh; Puntip Tantiwong; C S Reddy Meka; Phyllis Eagan; Christopher P Jenkinson; Eugenio Cersosimo; Ralph A Defronzo; Dawn K Coletta; Apiradee Sriwijitkamol; Nicolas Musi Journal: Diabetes Date: 2008-07-15 Impact factor: 9.461
Authors: V Ilievski; U G Bhat; S Suleiman-Ata; B A Bauer; P T Toth; S T Olson; T G Unterman; K Watanabe Journal: J Periodontal Res Date: 2017-06-23 Impact factor: 4.419
Authors: Vladimir Ilievski; Yale Cho; Priya Katwala; Heriberto Rodriguez; Margaret Tulowiecka; David Kurian; Lara Leoni; John W Christman; Terry G Unterman; Keiko Watanabe Journal: PLoS One Date: 2015-08-28 Impact factor: 3.240
Authors: Mohammed S AlQranei; Linda T Senbanjo; Hanan Aljohani; Therwa Hamza; Meenakshi A Chellaiah Journal: BMC Immunol Date: 2021-03-25 Impact factor: 3.615